Target intelligence / Profile preview

Exportin for tRNA (XPOT)

Target
XPOT
Molecular classification
Transporter, Nuclear export receptor (karyopherin-β family), RAN-GTPase exportin family member
01

Overview

Exportin for tRNA (XPOT) is a nuclear export receptor belonging to the karyopherin-β/transportin family, specifically responsible for recognizing and exporting mature tRNAs from the nucleus to the cytoplasm in eukaryotic cells. XPOT functions by forming a ternary complex with tRNA and Ran-GTP, docking at the nuclear pore, and upon transport into the cytoplasm, the complex dissociates, freeing tRNA for translation. Structural studies reveal XPOT wraps around mature tRNA, providing specificity for correctly processed molecules and coupling export to tRNA quality control. XPOT is implicated in coordinating cellular protein synthesis with nuclear-cytoplasmic transport, and its dysregulation or overexpression has been linked to various cancers, where it supports abnormal cell proliferation and invasion. No clinical drugs directly target XPOT, but the molecule is being explored as a potential biomarker and future therapeutic target in oncology.

Other names
Exportin-TXPO3Exportin(tRNA)tRNA exportinexportin for tRNAexportin-texportin (tRNA)exportin, tRNA (nuclear export receptor for tRNAs)exportin, tRNA
02

Mechanism of action

No direct-acting drugs; experimental strategies include RNA interference or genetic knockdown in research. Potential mechanisms would involve inhibition of tRNA nuclear export leading to impaired protein synthesis, cytokinesis failure, and reduced tumor proliferation

03

Biological functions

Nuclear export of tRNA (mediates the transport of tRNAs from the nucleus to the cytoplasm)Quality control of tRNA processing (distinguishing mature from improperly processed tRNAs)Regulation of protein translation (by ensuring export of mature tRNAs)Cell cycle progression and cytokinesis (through ensuring correct translation of proteins involved in mitosis)
04

Disease associations

Cancer (upregulated in hepatocellular carcinoma, breast cancer, neuroblastoma, and malignant pleural mesothelioma; promotes tumor proliferation, migration, invasion)Intellectual developmental disorder (autosomal dominant 10)Possible link to apoptosis resistance in macrophages
05

Safety considerations

Essential for normal cell viability (XPOT is necessary for fundamental cellular processes; inhibition could result in broad toxicity by disrupting global protein synthesis in healthy cells)Possible cell cycle/cytokinesis defects (inhibition may yield multinucleation or cell division failure)
06

Interacting drugs

None identified (as of current knowledge, no small molecule or biologic directly targeting XPOT is clinically available or reported in databases)
07

Biomarkers

XPOT overexpression (prognostic in hepatocellular carcinoma, neuroblastoma, breast cancer; high expression correlates with poor prognosis and increased malignancy)

Beyond the preview

Go deeper on Exportin for tRNA (XPOT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exportin for tRNA (XPOT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call